GLP-1 medications linked to fewer deaths and amputations in people with type 2 diabetes and PAD

According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist (GLP-1 RA) medications reduce the number of deaths, amputations and hospitalizations among people with type 2 diabetes who also have narrowed leg arteries associated with PAD (peripheral artery disease).